CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE: RMED) hires Thomas Fogarty as Chief Commercial Officer, effectively immediately. Mr. Fogarty brings over two decades of medical ...
CARLSBAD, Calif.--(BUSINESS WIRE)--Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focusing on developing its excimer laser system to treat vascular disease, reports financial ...
CARLSBAD, Calif., Following the €1.9 billion ($2.16 billion) purchase of The Spectranetics Corporation by Royal Philips, Ra Medical Systems, makers of cardiovascular and dermatology catheters and ...
CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED), a medical device company focused on developing its excimer laser system to treat vascular diseases, announces ...
The shares of commercial-stage medical device maker Ra Medical Systems (RMED) have tumbled 92.7% in price over the past year due to investor concerns surrounding the company’s poor financial health.
CARLSBAD, Calif.--(BUSINESS WIRE)-- Ra Medical Systems, Inc. (NYSE American: RMED) today announced it has entered into a settlement agreement that resolves civil False Claims Act claims asserted by ...
Peripheral artery disease (PAD) is a narrowing of the arteries in the extremities that reduces blood flow to those limbs. Estimates of prevalence in the US vary widely, from 8.5 million by the CDC, to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results